300 related articles for article (PubMed ID: 37743502)
1. Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review.
Asnaashari S; Amjad E; Sokouti B
Cancer Cell Int; 2023 Sep; 23(1):211. PubMed ID: 37743502
[TBL] [Abstract][Full Text] [Related]
2. The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives.
Mottaghi S; Abbaszadeh H
Phytother Res; 2021 Dec; 35(12):6843-6861. PubMed ID: 34498311
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo.
Tan KT; Li S; Li YR; Cheng SL; Lin SH; Tung YT
Appl Biochem Biotechnol; 2019 Apr; 187(4):1328-1343. PubMed ID: 30229430
[TBL] [Abstract][Full Text] [Related]
5. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anticancer effect of flavonoids from Sophora alopecuroides with Sorafenib against hepatocellular carcinoma.
Zhu XF; Sun ZL; Ma J; Hu B; Yu MC; Liu XJ; Yang P; Xu Y; Ju D; Mu Q
Phytother Res; 2023 Feb; 37(2):592-610. PubMed ID: 36180975
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines.
Doğan Şiğva ZÖ; Balci Okcanoğlu T; Biray Avci Ç; Yilmaz Süslüer S; Kayabaşi Ç; Turna B; Dodurga Y; Nazli O; Gündüz C
Gene; 2019 Mar; 687():261-271. PubMed ID: 30453074
[TBL] [Abstract][Full Text] [Related]
8. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
9. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells.
Xu Y; Xin Y; Diao Y; Lu C; Fu J; Luo L; Yin Z
PLoS One; 2011; 6(12):e29169. PubMed ID: 22216199
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
[No Abstract] [Full Text] [Related]
12. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.
Galati G; O'Brien PJ
Free Radic Biol Med; 2004 Aug; 37(3):287-303. PubMed ID: 15223063
[TBL] [Abstract][Full Text] [Related]
13. Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib.
Ding K; Jiang W; Jia H; Lei M
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358997
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
16. The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment.
Rahmani AH; Almatroudi A; Allemailem KS; Khan AA; Almatroodi SA
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558146
[TBL] [Abstract][Full Text] [Related]
17. Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
Bokemeyer C; Hartmann JT; Kuczyk MA; Truss MC; Kollmannsberger C; Beyer J; Jonas U; Kanz L
World J Urol; 1998; 16(2):155-62. PubMed ID: 12073232
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways.
Qattan MY; Khan MI; Alharbi SH; Verma AK; Al-Saeed FA; Abduallah AM; Al Areefy AA
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557997
[TBL] [Abstract][Full Text] [Related]
19. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways of taxanes-induced apoptosis.
Ganansia-Leymarie V; Bischoff P; Bergerat JP; Holl V
Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):291-306. PubMed ID: 12769774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]